Stage-oe-small.jpg

Thema4404: Unterschied zwischen den Versionen

Aus Aifbportal
Wechseln zu:Navigation, Suche
(Die Seite wurde neu angelegt: „{{Abschlussarbeit |Titel=Digital Health: Distributed Ledger Technology for Genomics |Abschlussarbeitstyp=Bachelor, Master |Betreuer=Scott Thiebes |Forschungsgr…“)
 
Zeile 7: Zeile 7:
 
|Beginn=2018/12/18
 
|Beginn=2018/12/18
 
|Beschreibung DE=<strong>Background:</strong>
 
|Beschreibung DE=<strong>Background:</strong>
 +
 +
Recently, Distributed ledger technology (DLT; e.g., Blockchain) emerged as a means to enable immutable transactions between untrustworthy parties, which are kept in a consistent state through automated, algorithm-based consensus building mechanisms, thus eliminating the need for third-party trust enforcement. In genomics, DLT’s recent popularity has led to the formation of several startups that mostly aim to establish market places where individuals can resell access to their personal genome data in exchange for some crypto currencies. However, these platforms are still in their infancy and many questions with regard to the application of DLT in genomics remain unanswered.
 +
 +
 +
<strong>Objective(s):</strong>
 +
 +
The objective of this thesis is to conceptualize and develop a prototype of a DLT-based genome data sharing platform.
 +
 +
 +
<strong>Introductory literature:</strong>
 +
 +
https://genome.cshlp.org/content/28/9/1255.short
 +
 +
https://academic.oup.com/jamia/advance-article/doi/10.1093/jamia/ocy149/5211361|Beschreibung EN=<strong>Background:</strong>
  
 
Recently, Distributed ledger technology (DLT; e.g., Blockchain) emerged as a means to enable immutable transactions between untrustworthy parties, which are kept in a consistent state through automated, algorithm-based consensus building mechanisms, thus eliminating the need for third-party trust enforcement. In genomics, DLT’s recent popularity has led to the formation of several startups that mostly aim to establish market places where individuals can resell access to their personal genome data in exchange for some crypto currencies. However, these platforms are still in their infancy and many questions with regard to the application of DLT in genomics remain unanswered.
 
Recently, Distributed ledger technology (DLT; e.g., Blockchain) emerged as a means to enable immutable transactions between untrustworthy parties, which are kept in a consistent state through automated, algorithm-based consensus building mechanisms, thus eliminating the need for third-party trust enforcement. In genomics, DLT’s recent popularity has led to the formation of several startups that mostly aim to establish market places where individuals can resell access to their personal genome data in exchange for some crypto currencies. However, these platforms are still in their infancy and many questions with regard to the application of DLT in genomics remain unanswered.
Zeile 21: Zeile 35:
  
 
https://academic.oup.com/jamia/advance-article/doi/10.1093/jamia/ocy149/5211361
 
https://academic.oup.com/jamia/advance-article/doi/10.1093/jamia/ocy149/5211361
 +
 
}}
 
}}

Version vom 19. Februar 2019, 15:18 Uhr



Digital Health: Distributed Ledger Technology for Genomics




Informationen zur Arbeit

Abschlussarbeitstyp: Bachelor, Master
Betreuer: Scott Thiebes
Forschungsgruppe: Critical Information Infrastructures

Archivierungsnummer: 4404
Abschlussarbeitsstatus: Offen
Beginn: 18. Dezember 2018
Abgabe: unbekannt

Weitere Informationen

Background:

Recently, Distributed ledger technology (DLT; e.g., Blockchain) emerged as a means to enable immutable transactions between untrustworthy parties, which are kept in a consistent state through automated, algorithm-based consensus building mechanisms, thus eliminating the need for third-party trust enforcement. In genomics, DLT’s recent popularity has led to the formation of several startups that mostly aim to establish market places where individuals can resell access to their personal genome data in exchange for some crypto currencies. However, these platforms are still in their infancy and many questions with regard to the application of DLT in genomics remain unanswered.


Objective(s):

The objective of this thesis is to conceptualize and develop a prototype of a DLT-based genome data sharing platform.


Introductory literature:

https://genome.cshlp.org/content/28/9/1255.short

https://academic.oup.com/jamia/advance-article/doi/10.1093/jamia/ocy149/5211361